Share Market (Social Media)
Business News: The Indian stock market on Friday recorded a huge decline after US President Donald Trump's announcement of imposing 100% tariffs on the import of branded and patent drugs from 1 October. The BSE Sensex fell over 800 points to 80,400 levels during trading. Finally, the Sensex closed at 80,426.46 points, declining 733.22 points, or 0.90%. At the same time, the Nifty 50 also fell 238.35 points i.e. 0.96% to close at 24,652.50 points.
After Trump's decision, the most pressure was seen in the shares of Indian pharma companies. The Nifty Pharma fell 590 points or 2.7% to the lowest level of the day of 21,390.25. Of the 20 shares of this sector, 17 were in red mark. Large shares like Laus Labs, Biocon, Zayadas LifeSyins and Natco Pharma have fallen by up to 7%. Investors considered it a negative sign.
The stock market was under pressure this week in the sixth consecutive season. The Sensex has fallen more than 1,850 points from Monday to Friday. The Nifty 50 has also broken about 600 points this week. According to experts, besides the US tariff decision, the selling of foreign institutional investors was also the main cause of pressure in the market.
On Friday, Asian markets also saw a fall pressure. Japan's Nikkei was 0.9%, Hong Kong's Hang Seng 1.4% and China's Shanghai Composite was 0.7% below. Heavy selling of foreign investors was also affected on the domestic market. On Thursday, FIIS sold shares worth Rs 4,995.42 crore. So far in September, he has sold domestic shares worth Rs 13,450 crore and so far in the year 2025, Rs 1,44,085 crore.
Financial analysts say Trump's tariff decision has affected the global sales and benefits of Indian pharma companies. This increased the fear of foreign investors and continued selling in the market.
Copyright © 2025 Top Indian News
